Disc Medicine, Inc. (IRON)
65.59
-0.23
(-0.35%)
USD |
NASDAQ |
Apr 07, 14:53
Disc Medicine SG&A Expense (TTM) : 65.38M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Boston Scientific Corp. | 6.888B |
| Penumbra, Inc. | 663.42M |
| Amylyx Pharmaceuticals, Inc. | 62.89M |
| Emergent BioSolutions, Inc. | 186.10M |